HemaSphere

HemaSphere, as a publication, is dedicated to disseminating the outcomes of profoundly pertinent basic, translational, and clinical research endeavors within the field of hematology. The journal actively seeks robust studies that unveil novel discoveries with significant ramifications for hematology. In addition to original research, HemaSphere features review articles and guideline articles that furnish lucid synopses and discussions of emerging developments, along with recommendations for patient care. Positioned as the foremost resource in hematology, HemaSphere augments its offerings with specialized sections like HemaTopics and HemaPolicy. These segments engender insightful dialogues covering a spectrum of hematology-related topics, including digestible summaries of pivotal articles, updates on new therapies, deliberations on European policy matters, and other noteworthy news items within the field. Steering the course of HemaSphere are Editor in Chief Jan Cools and Deputy Editor in Chief Claire Harrison, alongside the guidance of an esteemed Editorial Board comprising international luminaries in both research and clinical realms, each representing diverse areas of hematologic expertise.

《HemaSphere》发表高度相关的血液学基础、转化和临床研究成果。期刊主要寻找报告对血液学领域具有重大影响的新颖发现的强有力的研究。评论文章和指南文章提供了对新发展的清晰概述和讨论以及患者护理的建议。 该期刊​是首要的血液学信息资源，该期刊的 HemaTopics 和 HemaPolicy 部分进一步增强了这一资源。这些部分提供了与血液学相关的所有方面的深入讨论，包括重要文章的摘要、新疗法的报告、欧洲政策的讨论以及其他血液学新闻。